Short description
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
Description
ReViral is a developer of antiviral drugs designed to help patients and enlarge the antiviral market by developing novel first-in-class compounds. The company's antiviral drugs is a fusion inhibitor of RSV which is a highly potent, novel small molecule and is being developed to treat RSV in patients with severe disease including neonates, enabling patients to be treated who are infected with respiratory syncytial virus (RSV) by developing novel compounds.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Stevenage, Herefordshire, United Kingdom, Europe
Founded on
January 1, 2011
Exited on
April 7, 2022
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Uh Ohhhh, Absolutely Noaccess, Blurry Noaccess, Noaccessforu, No Way, Nopepepe, Noaccessforu, Noaccessforu, Cannot Access
Sign in for full access
Founders
Ken Powell, Neil Mathews, Stuart Cockerill